Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus. - Van de Ree,M.A.; Huisman,M.V.; Princen,H.MG.; Meinders,A.E.; Kluft,C. (Atherosclerosis, 2003)